Retatrutide Knee-Pain Results Published: What Two Phase 3 Trials Show About Osteoarthritis

A new NEJM publication reports less knee pain and greater weight loss with retatrutide in two Phase 3 trials. The analysis methods, serious adverse events, and limits on joint-repair claims are important parts of the findings.

For research use only. Not for human consumption.